Outset Medical (OM) to Release Quarterly Earnings on Wednesday

Share on StockTwits

Outset Medical (NASDAQ:OM) is scheduled to be announcing its earnings results after the market closes on Wednesday, May 5th. Analysts expect the company to announce earnings of ($0.86) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Outset Medical (NASDAQ:OM) last issued its earnings results on Monday, March 8th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.09). The company had revenue of $17.25 million during the quarter, compared to analyst estimates of $13.79 million. On average, analysts expect Outset Medical to post $-10 EPS for the current fiscal year and $-5 EPS for the next fiscal year.

Shares of NASDAQ OM opened at $57.83 on Tuesday. The business has a fifty day simple moving average of $54.20 and a 200 day simple moving average of $53.59. The company has a debt-to-equity ratio of 0.08, a quick ratio of 10.77 and a current ratio of 11.13. Outset Medical has a one year low of $42.50 and a one year high of $66.96.

A number of research analysts recently commented on the company. Zacks Investment Research lowered Outset Medical from a “buy” rating to a “hold” rating in a research note on Friday. Morgan Stanley increased their price objective on Outset Medical from $52.00 to $58.00 and gave the stock an “equal weight” rating in a research note on Tuesday, March 16th. Finally, Wells Fargo & Company assumed coverage on Outset Medical in a research note on Monday, April 26th. They set an “overweight” rating and a $63.00 price objective for the company. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $59.00.

In related news, General Counsel John L. Brottem sold 3,500 shares of the firm’s stock in a transaction dated Thursday, March 18th. The stock was sold at an average price of $47.71, for a total value of $166,985.00. Following the transaction, the general counsel now owns 18,172 shares in the company, valued at $866,986.12. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Warburg Pincus Llc sold 3,890,723 shares of the firm’s stock in a transaction dated Tuesday, April 13th. The shares were sold at an average price of $50.83, for a total value of $197,765,450.09. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,013,769 shares of company stock valued at $204,470,390.

About Outset Medical

Outset Medical, Inc, a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings.

Featured Article: Why is insider trading harmful?

Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.